Nutrien Ltd. (NYSE:NTR) Receives $82.75 Consensus Target Price from Analysts

Nutrien Ltd. (NYSE:NTRGet Free Report) has earned an average recommendation of “Moderate Buy” from the twenty brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and eleven have issued a buy recommendation on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $81.7059.

Several equities research analysts have weighed in on the company. Royal Bank Of Canada increased their price objective on Nutrien from $80.00 to $85.00 and gave the stock an “outperform” rating in a report on Tuesday, April 7th. Oppenheimer increased their price objective on Nutrien from $80.00 to $82.00 and gave the stock an “outperform” rating in a report on Tuesday, May 12th. BMO Capital Markets increased their price objective on Nutrien from $85.00 to $90.00 and gave the stock an “outperform” rating in a report on Wednesday, March 18th. JPMorgan Chase & Co. increased their price objective on Nutrien from $78.00 to $80.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Finally, Scotiabank increased their price objective on Nutrien from $75.00 to $80.00 and gave the stock a “sector perform” rating in a report on Monday, May 11th.

View Our Latest Report on Nutrien

Nutrien Price Performance

NTR opened at $67.65 on Friday. The stock’s 50 day simple moving average is $71.34 and its 200 day simple moving average is $69.17. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.24 and a quick ratio of 0.59. Nutrien has a 1 year low of $53.03 and a 1 year high of $85.36. The firm has a market cap of $32.47 billion, a price-to-earnings ratio of 13.78, a PEG ratio of 0.62 and a beta of 0.60.

Nutrien (NYSE:NTRGet Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.03. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The business had revenue of $6.05 billion for the quarter, compared to analyst estimates of $5.30 billion. During the same period last year, the company earned $0.11 EPS. Nutrien’s revenue for the quarter was up 18.5% compared to the same quarter last year. As a group, analysts predict that Nutrien will post 5.45 earnings per share for the current year.

Nutrien Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 17th. Shareholders of record on Tuesday, June 30th will be issued a $0.55 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.20 annualized dividend and a yield of 3.3%. Nutrien’s dividend payout ratio (DPR) is 44.81%.

Institutional Investors Weigh In On Nutrien

Several institutional investors and hedge funds have recently bought and sold shares of NTR. Wellington Management Group LLP lifted its holdings in Nutrien by 440.2% in the 4th quarter. Wellington Management Group LLP now owns 16,338,606 shares of the company’s stock worth $1,008,713,000 after buying an additional 13,313,817 shares during the period. Norges Bank purchased a new position in shares of Nutrien in the 4th quarter valued at approximately $412,635,000. Arrowstreet Capital Limited Partnership lifted its stake in shares of Nutrien by 19.1% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 14,221,381 shares of the company’s stock valued at $834,962,000 after purchasing an additional 2,276,651 shares during the period. TD Asset Management Inc lifted its stake in shares of Nutrien by 21.2% in the 4th quarter. TD Asset Management Inc now owns 8,928,534 shares of the company’s stock valued at $551,821,000 after purchasing an additional 1,559,673 shares during the period. Finally, DJE Kapital AG lifted its stake in shares of Nutrien by 1,373.6% in the 1st quarter. DJE Kapital AG now owns 1,534,869 shares of the company’s stock valued at $116,111,000 after purchasing an additional 1,430,708 shares during the period. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Featured Stories

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.